Transitional cell carcinoma natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
After treatment for bladder cancer, patient should be closely monitored for return of cancer. This may include: | After treatment for bladder cancer, patient should be closely monitored for return of cancer. This may include: | ||
*Bone scans and CT scans to check for the spread or return of cancer | *Bone scans and CT scans to check for the spread or return of cancer | ||
Monitoring symptoms that might suggest the disease is getting worse, such as fatigue, weight loss, increased pain, decreased bowel and bladder function, and weakness | *Monitoring symptoms that might suggest the disease is getting worse, such as fatigue, weight loss, increased pain, decreased bowel and bladder function, and weakness | ||
*Complete blood count (CBC) to monitor for anemia | *Complete blood count (CBC) to monitor for anemia | ||
*Bladder exams every 3 to 6 months after treatment | *Bladder exams every 3 to 6 months after treatment | ||
| Line 22: | Line 22: | ||
The cure rates for people with stage III tumors are less than 50%. Patients with stage IV bladder cancer are rarely cured. | The cure rates for people with stage III tumors are less than 50%. Patients with stage IV bladder cancer are rarely cured. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 20:46, 10 September 2012
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma natural history, complications and prognosis |
|
FDA on Transitional cell carcinoma natural history, complications and prognosis |
|
CDC on Transitional cell carcinoma natural history, complications and prognosis |
|
Transitional cell carcinoma natural history, complications and prognosis in the news |
|
Blogs on Transitional cell carcinoma natural history, complications and prognosis |
|
Directions to Hospitals Treating Transitional cell carcinoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Complications
Bladder cancers may spread into the nearby organs. They may also travel through the pelvic lymph nodes and spread to the liver, lungs, and bones. Additional complications of bladder cancer include:
- Anemia
- Swelling of the ureters(hydronephrosis)
- Urethral stricture
- Urinary incontinence
Prognosis
How well a patient with bladder cancer does depends on the initial stage and response to treatment of the bladder cancer.
The outlook for stage 0 or I cancers is fairly good. Although the risk of the cancer returning is high, most bladder cancers that return can be surgically removed and cured. After treatment for bladder cancer, patient should be closely monitored for return of cancer. This may include:
- Bone scans and CT scans to check for the spread or return of cancer
- Monitoring symptoms that might suggest the disease is getting worse, such as fatigue, weight loss, increased pain, decreased bowel and bladder function, and weakness
- Complete blood count (CBC) to monitor for anemia
- Bladder exams every 3 to 6 months after treatment
- Urinalysis if you did not have your bladder removed
The cure rates for people with stage III tumors are less than 50%. Patients with stage IV bladder cancer are rarely cured.